What’s new in GINA 2024?
GINA 2024 update published 22 May 2024
Download from [Link]
GINA Global Strategy for Asthma
Management and Prevention
This slide set is restricted for academic and educational purposes only.
No additions or changes may be made to slides. Use of the slide set or of individual
slides for commercial or promotional purposes requires approval from GINA.
Confidential © Global Initiative for Asthma
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Confidential
Asthma
Asthma is a chronic lung condition characterized by inflammation
and narrowing of the airways, which makes it difficult to breathe.
Confidential
Etiology
Outdoor Indoor Food Allergens
Substances Substances • Fish
• Pollen • Mold • Shellfish
• Smoke • Pet dander • Eggs
• Pollution • Dust mites • Peanuts
• Cold weather • Cockroach droppings • Soy
Confidential
Product Profile
Brand Name B-Form
Generic Name Budesonide + Formoterol fumarate
Strengths & Dosage 200mcg + 6mcg
400mcg + 12mcg
Pack Size 30’s
Class of Drug Corticosteroid and LABA
SciAir device video link
Indication Asthma & COPD
[Link]
Confidential
Mechanism of action
BUDESONIDE (Inhaled Corticosteroid (ICS))
• Inhibits the production of inflammatory chemicals which results in reduce Cough,
Wheezing & Bronchospasm (narrowing of bronchi).
FORMOTEROL long-acting β2-adrenergic agonist (LABA)
• Binds to smooth muscle cells of lungs and causes Bronchodilation (relaxation of airway
smooth muscle).
• Also, reduces airway inflammation.
GINA & GOLD 2024, guidelines recommends BUDESONIDE + FORMOTEROL as choice of treatment for Asthma
& COPD respectively.
Confidential
B-Form
Provides
Reduction of muscle Reduction of mucus
Reduction in airway
constriction of secretion in
Inflammation
airway walls airways
Confidential
Confidential
Confidential
Confidential
TYO
Confidential
Question
& Answer
Confidential
